These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22104957)

  • 1. Narrow-band imaging flexible cystoscopy in the detection of clinically unconfirmed positive urine cytology.
    Zhu YP; Shen YJ; Ye DW; Wang CF; Yao XD; Zhang SL; Dai B; Zhang HL; Shi GH
    Urol Int; 2012; 88(1):84-7. PubMed ID: 22104957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Narrow band imaging cystoscopy improves the detection of non-muscle-invasive bladder cancer.
    Cauberg EC; Kloen S; Visser M; de la Rosette JJ; Babjuk M; Soukup V; Pesl M; Duskova J; de Reijke TM
    Urology; 2010 Sep; 76(3):658-63. PubMed ID: 20223505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying narrow-band imaging in complement with white-light imaging cystoscopy in the detection of urothelial carcinoma of the bladder.
    Chen G; Wang B; Li H; Ma X; Shi T; Zhang X
    Urol Oncol; 2013 May; 31(4):475-9. PubMed ID: 22079940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hexylaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology.
    Ray ER; Chatterton K; Khan MS; Thomas K; Chandra A; O'Brien TS
    BJU Int; 2009 May; 103(10):1363-7. PubMed ID: 19076151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences.
    Herr HW; Donat SM
    BJU Int; 2008 Nov; 102(9):1111-4. PubMed ID: 18778359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Narrow-band imaging flexible cystoscopy in the detection of primary non-muscle invasive bladder cancer: a "second look" matters?
    Shen YJ; Zhu YP; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Zhu Y
    Int Urol Nephrol; 2012 Apr; 44(2):451-7. PubMed ID: 21792663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Narrow-band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder.
    Bryan RT; Billingham LJ; Wallace DM
    BJU Int; 2008 Mar; 101(6):702-5; discussion 705-6. PubMed ID: 18005206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoma in situ of the urinary bladder - from pathology to narrow band imaging.
    Geavlete BF; Brînzea A; ChecheriŢă IA; Zurac SA; Georgescu DA; Bastian AE; Ene CV; Bulai CA; Geavlete DO; Zaharia MR; Geavlete PA
    Rom J Morphol Embryol; 2015; 56(3):1069-76. PubMed ID: 26662141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of narrow-band versus white-light cystoscopy for restaging (second-look) transurethral resection of bladder tumors.
    Herr HW
    Eur Urol; 2015 Apr; 67(4):605-8. PubMed ID: 25041849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Narrow band imaging cystoscopy and bipolar plasma vaporization for large nonmuscle-invasive bladder tumors--results of a prospective, randomized comparison to the standard approach.
    Geavlete B; Multescu R; Georgescu D; Stanescu F; Jecu M; Geavlete P
    Urology; 2012 Apr; 79(4):846-51. PubMed ID: 22342408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of fluorescence in situ hybridization assay for surveillance of non-muscle invasive bladder cancer.
    Karnwal A; Venegas R; Shuch B; Bassett J; Rajfer J; Reznichek R
    Can J Urol; 2010 Apr; 17(2):5077-81. PubMed ID: 20398445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of routine transurethral biopsy and isolated upper tract cytology after intravesical treatment of high-grade non-muscle invasive bladder cancer.
    Lightfoot AJ; Rosevear HM; Nepple KG; O'Donnell MA
    Int J Urol; 2012 Nov; 19(11):988-93. PubMed ID: 22762480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narrow-band imaging (NBI) and white light (WLI) transurethral resection of the bladder in the treatment of non-muscle-invasive bladder cancer.
    Montanari E; de la Rosette J; Longo F; Del Nero A; Laguna P
    Arch Ital Urol Androl; 2012 Dec; 84(4):179-83. PubMed ID: 23427740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
    Kumar A; Kumar R; Gupta NP
    Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings.
    Bergman J; Reznichek RC; Rajfer J
    BJU Int; 2008 Jan; 101(1):26-9. PubMed ID: 17850364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive urine cytology but negative white-light cystoscopy: an indication for fluorescence cystoscopy?
    Karl A; Tritschler S; Stanislaus P; Gratzke C; Tilki D; Strittmatter F; Knüchel R; Stief CG; Zaak D
    BJU Int; 2009 Feb; 103(4):484-7. PubMed ID: 18793301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
    Blick CG; Nazir SA; Mallett S; Turney BW; Onwu NN; Roberts IS; Crew JP; Cowan NC
    BJU Int; 2012 Jul; 110(1):84-94. PubMed ID: 22122739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient diagnostic of bladder tumours in flexible cystoscopes: evaluation of fluorescence-guided flexible cystoscopy and bladder biopsies.
    Hermann GG; Mogensen K; Toft BG; Glenthøj A; Pedersen HM
    Scand J Urol Nephrol; 2012 Feb; 46(1):31-6. PubMed ID: 22150596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing treatment response after induction Bacillus Calmette-Guerin for carcinoma in situ of the urinary bladder: can post-induction random bladder biopsies be avoided?
    Smith PJ; Lotan Y; Raj GV; Sagalowsky AI; Margulis V
    Cytopathology; 2014 Apr; 25(2):108-11. PubMed ID: 23551700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.